Scarica l'app Stockscreener
20.99
3.76%
-0.82
Dopo l'orario di chiusura:
20.58
-0.41
-1.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$21.81
Aprire:
$21.85
Volume 24 ore:
1.59M
Relative Volume:
2.09
Capitalizzazione di mercato:
$1.71B
Reddito:
$305.00K
Utile/perdita netta:
$-328.98M
Rapporto P/E:
-5.4804
EPS:
-3.83
Flusso di cassa netto:
$-309.60M
1 W Prestazione:
-3.05%
1M Prestazione:
+5.90%
6M Prestazione:
+83.96%
1 anno Prestazione:
-4.59%
Intervallo 1D:
$20.78
$22.05
Intervallo di 1 settimana:
$20.69
$22.36
Portata 52W:
$9.90
$27.20
Viridian Therapeutics Inc Stock (VRDN) Company Profile
Nome
Viridian Therapeutics Inc
Settore
Industria
Telefono
617.272.4600
Indirizzo
221 CRESCENT STREET, WALTHAM
Confronta VRDN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
20.99 | 1.78B | 305.00K | -328.98M | -309.60M | -3.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Ripresa | Jefferies | Buy |
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-25 | Iniziato | TD Cowen | Buy |
| 2024-09-11 | Reiterato | Needham | Buy |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-05-09 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2023-06-14 | Iniziato | BTIG Research | Buy |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-05-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-04-17 | Iniziato | Wells Fargo | Overweight |
| 2023-03-30 | Iniziato | Stifel | Buy |
| 2022-12-19 | Iniziato | Cowen | Outperform |
| 2022-12-19 | Iniziato | Needham | Buy |
| 2022-12-16 | Iniziato | Credit Suisse | Outperform |
| 2022-12-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-11-18 | Iniziato | SVB Leerink | Outperform |
| 2021-10-12 | Iniziato | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie
Why Viridian Therapeutics Inc. is moving todayWeekly Trade Recap & Scalable Portfolio Growth Methods - newser.com
Is Viridian Therapeutics Inc. (1S1) stock protected from inflationMarket Risk Report & Pattern Based Trade Signal System - newser.com
Viridian Therapeutics’ (VRDN) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
Is Viridian Therapeutics Inc. stock safe for conservative investors2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Viridian Therapeutics supports key conferences with sponsorship initiative - Traders Union
Weiss Ratings Reaffirms "Sell (D-)" Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat
How Viridian Therapeutics Inc. stock reacts to bond yieldsQuarterly Market Review & High Return Trade Opportunity Guides - newser.com
Real time alert setup for Viridian Therapeutics Inc. performanceBear Alert & Real-Time Volume Surge Alerts - newser.com
Is Viridian Therapeutics Inc. stock dividend yield sustainable2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Viridian Therapeutics, Inc. $VRDN Shares Acquired by J. Safra Sarasin Holding AG - MarketBeat
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2025 - BioSpace
Viridian Therapeutics announces inducement grants under Nasdaq Listing Rule - MarketScreener
Voya Investment Management LLC Sells 1,627 Shares of Viridian Therapeutics, Inc. $VRDN - Defense World
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Is Viridian Therapeutics Inc a good long term investmentHigh Frequency Trading Trends & In-Depth Analyst Ratings Explained Simply - earlytimes.in
What Viridian Therapeutics (VRDN)'s Phase 3 TED Trial Milestones Mean For Shareholders - Sahm
Viridian Therapeutics: De-Risked Leadership In Thyroid Eye Disease (NASDAQ:VRDN) - Seeking Alpha
Is Viridian Therapeutics Inc. stock bottoming outShort Setup & Safe Entry Momentum Stock Tips - newser.com
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $37.78 Consensus Target Price from Analysts - MarketBeat
Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Potential 93.73% Upside Amid Promising Clinical Trials - DirectorsTalk Interviews
What does recent volatility data suggest for Viridian Therapeutics Inc.Trend Reversal & Reliable Volume Spike Alerts - newser.com
A Look at Viridian Therapeutics’s Valuation Following Completion of Pivotal Phase III Trial Enrollment for VRDN-003 - Sahm
Rhumbline Advisers Acquires 4,621 Shares of Viridian Therapeutics, Inc. $VRDN - Defense World
Leerink Partners Keeps Their Buy Rating on Viridian Therapeutics (VRDN) - The Globe and Mail
Dividend Watch: Can Viridian Therapeutics Inc. expand its profit marginsMarket Movers & Consistent Profit Focused Trading Strategies - خودرو بانک
Insider Trends: Is Viridian Therapeutics Inc stock a good pick for beginnersJobs Report & AI Optimized Trade Strategies - خودرو بانک
Is Viridian Therapeutics Inc. forming a reversal pattern2025 Year in Review & Momentum Based Trading Ideas - newser.com
Will Viridian Therapeutics Inc benefit from geopolitical trendsJuly 2025 EndofMonth & High Win Rate Trade Tips - خودرو بانک
VIX Spike: Should I hold or sell Viridian Therapeutics Inc nowTrade Ideas & Consistent Return Investment Signals - خودرو بانک
Aug Big Picture: What is Viridian Therapeutics Incs 5 year growth outlookEarnings Recap Report & AI Enhanced Trading Signals - خودرو بانک
Building trade automation scripts for Viridian Therapeutics Inc.Market Risk Summary & Technical Buy Zone Confirmations - newser.com
Quarterly Trades: Will Viridian Therapeutics Inc benefit from geopolitical trendsWeekly Trend Summary & Fast Entry Momentum Alerts - خودرو بانک
VIX Spike: What is Viridian Therapeutics Incs 5 year growth outlookSwing Trade & Technical Pattern Based Signals - khodrobank.com
Is Viridian Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Viridian Therapeutics Inc Azioni (VRDN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director |
Jun 09 '25 |
Option Exercise |
7.80 |
1,600 |
12,480 |
3,447,413 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):